Deletion of ABH blood group isoantigen and prognosis in patients with transitional cell bladder carcinoma.
Malmström
P U
PU
Department of Urology, University Hospital, Uppsala, Sweden.
Busch
C
C
Norlen
B J
BJ
D000017:ABO Blood-Group System; D002295:Carcinoma, Transitional Cell / Q000097:blood* / Q000401:mortality; D005500:Follow-Up Studies; D006801:Humans; D011379:Prognosis; D012189:Retrospective Studies; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000097:blood* / Q000401:mortality
D000017:ABO Blood-Group System